Monopar Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $651k | 8.0k | 81.67 |
| 2025-06-30 | $783k | 22k | 35.78 |
| 2025-03-31 | $296k | 8.1k | 36.41 |
| 2024-12-31 | $141k | 6.4k | 22.00 |
| 2024-09-30 | $3.5k | 512 | 6.74 |